Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
The authors wanted to verify if in clinical practice (Intensive Care Unit patients), the association of azlocillin with an aminoglycoside offers substantial advantages compared to use of azlocillin alone. Their results show that azlocillin alone is potent enough to be used in the treatment of severe infections.
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000627:therapeutic use*; D001390:Azlocillin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D003422:Critical Care / Q000379:methods*; D003428:Cross Infection / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
D000583:Amikacin; D001390:Azlocillin